Shandong Weigao Group Medical Polymer Company Limited

DB:UK2 Stock Report

Market Cap: €2.6b

Shandong Weigao Group Medical Polymer Future Growth

Future criteria checks 2/6

Shandong Weigao Group Medical Polymer is forecast to grow earnings and revenue by 10.3% and 7.2% per annum respectively. EPS is expected to grow by 10.2% per annum. Return on equity is forecast to be 9.2% in 3 years.

Key information

10.3%

Earnings growth rate

10.2%

EPS growth rate

Medical Equipment earnings growth14.3%
Revenue growth rate7.2%
Future return on equity9.2%
Analyst coverage

Good

Last updated07 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:UK2 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202615,6392,5142,2013,5766
12/31/202514,7772,3301,9623,0137
12/31/202413,8692,1472,0862,7167
6/30/202412,9671,9122,0182,704N/A
3/31/202413,0981,9572,0662,751N/A
12/31/202313,2292,0022,1132,799N/A
9/30/202313,3982,2211,6392,539N/A
6/30/202313,5662,4401,1662,280N/A
3/31/202313,6572,6021,1732,287N/A
12/31/202213,7472,7641,1812,295N/A
9/30/202213,9032,6761,4332,573N/A
6/30/202214,0582,5891,6852,852N/A
3/31/202213,6332,4321,8032,969N/A
12/31/202113,2092,2761,9203,087N/A
9/30/202112,9232,2882,0213,088N/A
6/30/202112,6362,3002,1213,089N/A
3/31/202112,1292,1941,9712,938N/A
12/31/202011,6222,0871,8212,788N/A
9/30/202011,1391,9981,5572,533N/A
6/30/202010,6561,9091,2922,277N/A
3/31/202010,5201,8791,3152,300N/A
12/31/201910,3841,8501,3372,322N/A
9/30/20199,9931,8051,4562,347N/A
6/30/20199,6021,7601,5752,371N/A
3/31/20199,2051,6161,5002,295N/A
12/31/20188,8091,4731,4242,219N/A
6/30/20187,4651,2553831,812N/A
3/31/20186,8791,255N/A1,539N/A
12/31/20176,2931,255N/A1,266N/A
6/30/20175,4021,297N/A1,233N/A
3/31/20175,5111,165N/A1,143N/A
12/31/20165,6201,033N/A1,053N/A
9/30/20166,4841,010N/A1,042N/A
6/30/20166,237914N/A1,030N/A
3/31/20166,0781,013N/A1,041N/A
12/31/20155,9191,113N/A1,053N/A
9/30/20155,8781,237N/AN/AN/A
6/30/20155,6101,196N/A622N/A
3/31/20155,5481,161N/AN/AN/A
12/31/20145,2781,085N/A711N/A
9/30/20145,011307N/AN/AN/A
6/30/20144,996431N/A794N/A
3/31/20144,769376N/AN/AN/A
12/31/20134,613388N/A720N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: UK2's forecast earnings growth (10.3% per year) is above the savings rate (1%).

Earnings vs Market: UK2's earnings (10.3% per year) are forecast to grow slower than the German market (20.7% per year).

High Growth Earnings: UK2's earnings are forecast to grow, but not significantly.

Revenue vs Market: UK2's revenue (7.2% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: UK2's revenue (7.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: UK2's Return on Equity is forecast to be low in 3 years time (9.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y